bioRxiv Science⌕ Search

Biology subjects

Rossmanith, E.

Publications and source records attributed to Rossmanith, E..

2 recordsLinked to original sources

Enhanced in vivo gene knockout with undetectable off-targets using multiplexed Cas12a sgRNAs

CRISPR nuclease-mediated gene knock-out is limited by suboptimal sgRNAs, inaccessible target sites, and silent mutations. Here, we present a Cas12a-based system that targets each gene with four sgRNAs to overcome these limitations, using Drosophila as a tractable in vivo model. We show that multiplexed sgRNAs act synergistically to create deletions between target sites, substantially increasing the fraction of loss-of-function mutations. To systematically assess off-target effects, we developed a novel screening assay that visualizes CRISPR-induced chromosomal alterations in living animals. This enabled comprehensive screening of more than 2000 sgRNAs clustered in 525 quadruple arrays across 21 megabases of genomic DNA, revealing remarkably high on-target activity (100%, 82/82) and undetectable off-target cutting (0%, 0/443). Quantitative side-by-side comparisons with a current Cas9-based system targeting over 100 genes demonstrates that multiplexed Cas12a-mediated gene targeting achieves superior performance and reveals phenotypes missed by established methods. This highly efficient and specific system provides a framework for reliable functional genomics studies across diverse organisms.

genetics↗

Mesenchymal stem cells support human vascular endothelial cells to form vascular sprouts in human platelet lysate-based matrices.

During tissue regeneration, mesenchymal stem cells can support endothelial cells in the process of new vessel formation. For a functional interaction of endothelial cells with mesenchymal stem cells a vascular inductive microenvironment is required. Using a cellular model for neo-vessel formation, we could show that newly formed vascular structures emanated from the embedded aggregates, consisting of mesenchymal stem cells co-cultured with human umbilical vein endothelial cells, into the avascular HPL-based matrices bridging distances up to 5 mm to join with adjacent aggregates with the same morphology forming an interconnected network. These newly formed vascular sprouts showed branch points and generated a lumen as sign of mature vascular development. Mesenchymal stem cells in fluid phase could bind to and interact with adherent human umbilical vein endothelial cells when a shear-force of 2 dyne/mm2 was applied in the flow chamber using a Bioflux(R)200 device. Under these conditions, mesenchymal stem cells bind to human umbilical vein endothelial cells previously damaged by laser beam irradiation to interact and shed particles. In conclusion, we observed that mesenchymal stem cells support human umbilical vein endothelial cells to form new vessels in HPL-based matrices when co-cultured in spherical aggregates to generate complex vascular networks in a primarily avascular scaffold and bind to the damaged cells under shear-force to eventually aid in their regeneration.

bioengineering↗